DBV Technologies To Host And Webcast Investor Day In New York City On May 21, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGNEUX, France, May 12, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new paradigm for the treatment of food allergies, today announced that a live webcast of its Investor Day scheduled for Wednesday, May 21st will be available on the Company’s website, www.dbv-technologies.com, on the Investor Relations section. The presentation will begin at 8:30 AM Eastern Time (or 2:30 PM CET) at the Le Parker Meridien Hotel in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC